Europe Neuromodulation Market
Buy Now Request Sample Explore
Home › Report Store › Life Sciences  › Europe Neuromodulation Market

Europe Neuromodulation Market

The Europe Neuromodulation Market size was valued at US$ 2,296.33 Mn in 2019 and is projected to reach US$ 4,741.75 Mn by 2027, growing at a CAGR of 9.8% during 2020 - 2027.

Report Coverage
  • Technology: External Neuromodulation, Internal Neuromodulation
  • Application: Chronic Pain Management, Failed Back Syndrome, Epilepsy, Tremor, Incontinence, Depression, Dystonia, Gastroparesis, Parkinson's Disease, Obsessive-Compulsive Disorder, Migraine
  • End User: Hospitals, Clinics, Home Healthcare
US$ 2,296.33 Mn Market size in 2019
US$ 4,741.75 Mn Market Size by 2027
9.8% CAGR, 2020 - 2027
2020-2027 Forecast Period

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Europe Neuromodulation Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Europe Neuromodulation Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Europe Neuromodulation Market Regional Analysis

6.2 Europe Neuromodulation Market Revenue 2017-2027 (US$ Million)
6.3 Europe Neuromodulation Market Forecast Analysis

7. Europe Neuromodulation Market Analysis – by Technology

7.1 External Neuromodulation
  • 7.1.1 Overview
  • 7.1.2 External Neuromodulation: Europe Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Internal Neuromodulation
  • 7.2.1 Overview
  • 7.2.2 Internal Neuromodulation: Europe Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)

8. Europe Neuromodulation Market Analysis – by Application

8.1 Chronic Pain Management
  • 8.1.1 Overview
  • 8.1.2 Chronic Pain Management: Europe Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Failed Back Syndrome
  • 8.2.1 Overview
  • 8.2.2 Failed Back Syndrome: Europe Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Epilepsy
  • 8.3.1 Overview
  • 8.3.2 Epilepsy: Europe Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.4 Tremor
  • 8.4.1 Overview
  • 8.4.2 Tremor: Europe Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.5 Incontinence
  • 8.5.1 Overview
  • 8.5.2 Incontinence: Europe Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.6 Depression
  • 8.6.1 Overview
  • 8.6.2 Depression: Europe Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.7 Dystonia
  • 8.7.1 Overview
  • 8.7.2 Dystonia: Europe Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.8 Gastroparesis
  • 8.8.1 Overview
  • 8.8.2 Gastroparesis: Europe Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.9 Parkinson's Disease
  • 8.9.1 Overview
  • 8.9.2 Parkinson's Disease: Europe Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.10 Obsessive-Compulsive Disorder
  • 8.10.1 Overview
  • 8.10.2 Obsessive-Compulsive Disorder: Europe Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.11 Migraine
  • 8.11.1 Overview
  • 8.11.2 Migraine: Europe Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)

9. Europe Neuromodulation Market Analysis – by End User

9.1 Hospitals
  • 9.1.1 Overview
  • 9.1.2 Hospitals: Europe Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.2 Clinics
  • 9.2.1 Overview
  • 9.2.2 Clinics: Europe Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.3 Home Healthcare
  • 9.3.1 Overview
  • 9.3.2 Home Healthcare: Europe Neuromodulation Market – Revenue and Forecast, 2017-2027 (US$ Million)

10. Europe Neuromodulation Market – Europe Analysis

10.1 Overview

10.2 Europe
  • 10.2.1 Europe Neuromodulation Market Breakdown, by Key Country, 2020 and 2027 (%)
  • 10.2.1.1 Europe Neuromodulation Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 UK: Europe Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.2.1.1.1 UK: Europe Neuromodulation Market Breakdown, by Technology
    • 10.2.1.1.2 UK: Europe Neuromodulation Market Breakdown, by Application
    • 10.2.1.1.3 UK: Europe Neuromodulation Market Breakdown, by End User
  • 10.2.1.2 Germany: Europe Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.2.1.2.1 Germany: Europe Neuromodulation Market Breakdown, by Technology
    • 10.2.1.2.2 Germany: Europe Neuromodulation Market Breakdown, by Application
    • 10.2.1.2.3 Germany: Europe Neuromodulation Market Breakdown, by End User
  • 10.2.1.3 France: Europe Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.2.1.3.1 France: Europe Neuromodulation Market Breakdown, by Technology
    • 10.2.1.3.2 France: Europe Neuromodulation Market Breakdown, by Application
    • 10.2.1.3.3 France: Europe Neuromodulation Market Breakdown, by End User
  • 10.2.1.4 Russia: Europe Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.2.1.4.1 Russia: Europe Neuromodulation Market Breakdown, by Technology
    • 10.2.1.4.2 Russia: Europe Neuromodulation Market Breakdown, by Application
    • 10.2.1.4.3 Russia: Europe Neuromodulation Market Breakdown, by End User
  • 10.2.1.5 Italy: Europe Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.2.1.5.1 Italy: Europe Neuromodulation Market Breakdown, by Technology
    • 10.2.1.5.2 Italy: Europe Neuromodulation Market Breakdown, by Application
    • 10.2.1.5.3 Italy: Europe Neuromodulation Market Breakdown, by End User
  • 10.2.1.6 Rest of Europe: Europe Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.2.1.6.1 Rest of Europe: Europe Neuromodulation Market Breakdown, by Technology
    • 10.2.1.6.2 Rest of Europe: Europe Neuromodulation Market Breakdown, by Application
    • 10.2.1.6.3 Rest of Europe: Europe Neuromodulation Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 Abbott
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Boston Scientific Corporation
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Medtronic
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 NeuroPace, Inc.
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 NeuroSigma, Inc.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 NEVRO CORP.
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Synapse Biomedical Inc.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Soterix Medical Inc
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Integer Holdings Corporation
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Magstim
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

Access the Full E Market Report

Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.

Download Sample Request Customization
Access the full E Market Report
117 pages PDF & Excel | 2020-11-18
Download Sample Customization